Ozempic maker faces proposed class action lawsuit alleging ‘dangerous side effects’
Ozempic maker Novo Nordisk is facing a proposed class action lawsuit that alleges the company has not properly warned Canadians about severe side effects, including stomach paralysis and gallbladder disease. The proposed class action lawsuit was filed on Oct. 6 in British Columbia for alleged damages arising from Novo Nordisk’s drugs Ozempic, Rybelsus and Wegovy.